77 related articles for article (PubMed ID: 2579737)
1. Fatal pneumothorax following bleomycin and other cytotoxic drugs.
Leeser JE; Carr D
Cancer Treat Rep; 1985 Mar; 69(3):344-5. PubMed ID: 2579737
[No Abstract] [Full Text] [Related]
2. Cutaneous flagellate pigmentation by bleomycin.
Spedini P; Bergonzi C; Morandi S
Haematologica; 2000 Aug; 85(8):870. PubMed ID: 10942936
[No Abstract] [Full Text] [Related]
3. [Pulmonary sarcoid-like granulomatosis associated with Hodgkin's disease and complicated by bleomycin-induced pulmonary nodules].
Hirschi S; Lange F; Battesti JP; Lebargy F
Ann Med Interne (Paris); 1998 Apr; 149(3):164-6. PubMed ID: 11490540
[TBL] [Abstract][Full Text] [Related]
4. [Spontaneous pneumothorax in response to chemotherapy of metastatic germinal tumor].
Vicente P; Garciá del Muro X; Cardenal F
An Med Interna; 1995 Jun; 12(6):307-8. PubMed ID: 7548651
[No Abstract] [Full Text] [Related]
5. Pohl-Pinkus constrictions of hair following chemotherapy for Hodgkin's disease.
Williamson PJ; de Berker D
Br J Haematol; 2005 Mar; 128(5):582. PubMed ID: 15725077
[No Abstract] [Full Text] [Related]
6. Extensive pneumothorax, pneumomediastinum and surgical emphysema as a complication of bleomycin therapy.
Jain TP; Thulkar S; Saha S; Bakhshi S; Dominic J
Pediatr Radiol; 2005 Dec; 35(12):1227-9. PubMed ID: 16096827
[TBL] [Abstract][Full Text] [Related]
7. Vinblastine, bleomycin, and methotrexate chemotherapy plus irradiation for patients with early-stage, favorable Hodgkin lymphoma: the experience of the Gruppo Italiano Studio Linfomi.
Gobbi PG; Broglia C; Merli F; Dell'Olio M; Stelitano C; Iannitto E; Federico M; Bertè R; Luisi D; Molica S; Cavalli C; Dezza L; Ascari E
Cancer; 2003 Dec; 98(11):2393-401. PubMed ID: 14635074
[TBL] [Abstract][Full Text] [Related]
8. [The whole dose at once?].
Rodríguez García J; Ramos Ortega FJ; Sandoval Guerra V; García Sanz R
Sangre (Barc); 1996 Jun; 41(3):259. PubMed ID: 8755216
[No Abstract] [Full Text] [Related]
9. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
[TBL] [Abstract][Full Text] [Related]
10. How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen?
Canellos GP; Duggan D; Johnson J; Niedzwiecki D
J Clin Oncol; 2004 Apr; 22(8):1532-3. PubMed ID: 15084636
[No Abstract] [Full Text] [Related]
11. Acute myeloid leukemia following therapy of Hodgkin's disease with radiotherapy and ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine).
Lipton JH; Gospodarowicz M; Reingold S
Hematol Oncol; 1996 Mar; 14(1):29-31. PubMed ID: 8613133
[TBL] [Abstract][Full Text] [Related]
12. [Fatal bleomycin induced pneumomediastinum and bilateral pneumothorax].
Jennane S; Haidouri S; Zine Filali K; Ahchouch S; Mahtat EM; Doghmi K; Mikdame M
Rev Pneumol Clin; 2017 Jun; 73(3):153-156. PubMed ID: 28365047
[No Abstract] [Full Text] [Related]
13. [Lung infiltrations in Hodgkin lymphoma].
Ciurea-Löchel A; Ciurea A; Stey C; Pestalozzi B
Praxis (Bern 1994); 2001 Aug; 90(31-32):1307-11. PubMed ID: 11519195
[TBL] [Abstract][Full Text] [Related]
14. Male infertility caused by the chemotherapy of Hodgkin's disease: MOPP versus ABVD.
Ragni G; Lombardi C; Santoro A; Bestetti O; Wyssling H
Acta Eur Fertil; 1983; 14(3):221-2. PubMed ID: 6199937
[No Abstract] [Full Text] [Related]
15. MOPP/ABV/CAD chemotherapy with and without recombinant human granulocyte-macrophage colony stimulating factor in untreated, unfavorable prognosis Hodgkin's disease.
Riccardi A; Gobbi P; Danova M; Giordano M; Pieresca C; Bertoloni D; Brugnatelli S; Ascari E
Haematologica; 1993; 78(1):44-8. PubMed ID: 7684012
[TBL] [Abstract][Full Text] [Related]
16. Bleomycin-induced "flagellate dermatitis".
Arseculeratne G; Berroeta L; Meiklejohn D; Mountain RE; Ryan JC; Spinou C; Das SN; Evans AT; Lowe JG
Arch Dermatol; 2007 Nov; 143(11):1461-2. PubMed ID: 18025386
[No Abstract] [Full Text] [Related]
17. [Is the ABVD an optimal regimen for Hodgkins disease?].
Nakamura S
Rinsho Ketsueki; 1998 Feb; 39(2):109-10. PubMed ID: 9545813
[No Abstract] [Full Text] [Related]
18. Are ABVD and MOPP/ABV truly equivalent for treating Hodgkin's disease at advanced stages?
Andrieu JM; Colonna P
J Clin Oncol; 1998 Jun; 16(6):2283. PubMed ID: 9626234
[No Abstract] [Full Text] [Related]
19. The vanishing bile duct syndrome in a child with Hodgkin disease.
Ozkan A; Yoruk A; Celkan T; Apak H; Yildiz I; Ozbay G
Med Pediatr Oncol; 2001 Mar; 36(3):398-9. PubMed ID: 11241447
[No Abstract] [Full Text] [Related]
20. [Treating Hodgkin's disease: for whom the more means better?].
Illés A
Magy Onkol; 2004; 48(2):157-61. PubMed ID: 15351812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
